Nexstim Financial Statements From 2010 to 2024

NXTMH Stock  EUR 5.08  0.08  1.55%   
Nexstim Oyj financial statements provide useful quarterly and yearly information to potential Nexstim Oyj investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Nexstim Oyj financial statements helps investors assess Nexstim Oyj's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Nexstim Oyj's valuation are summarized below:
Nexstim Oyj does not presently have any fundamental ratios for analysis.
Check Nexstim Oyj financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nexstim Oyj's main balance sheet or income statement drivers, such as , as well as many indicators such as . Nexstim financial statements analysis is a perfect complement when working with Nexstim Oyj Valuation or Volatility modules.
  
This module can also supplement various Nexstim Oyj Technical models . Check out the analysis of Nexstim Oyj Correlation against competitors.

Nexstim Oyj Company Return On Equity Analysis

Nexstim Oyj's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Nexstim Oyj Return On Equity

    
  0.71  
Most of Nexstim Oyj's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nexstim Oyj is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Nexstim Oyj has a Return On Equity of 0.7079. This is 102.95% lower than that of the Health Care Equipment & Supplies sector and 108.11% lower than that of the Health Care industry. The return on equity for all Finland stocks is notably lower than that of the firm.

Nexstim Oyj Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Nexstim Oyj's current stock value. Our valuation model uses many indicators to compare Nexstim Oyj value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nexstim Oyj competition to find correlations between indicators driving Nexstim Oyj's intrinsic value. More Info.
Nexstim Oyj is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about  0.14  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Nexstim Oyj is roughly  7.06 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nexstim Oyj by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nexstim Oyj's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Nexstim Oyj Financial Statements

Investors use fundamental indicators, such as Nexstim Oyj's revenue or net income, to determine how well the company is positioned to perform in the future. Although Nexstim Oyj's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Nexstim Plc, a neuromodulation company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. Nexstim Plc was founded in 2000 and is headquartered in Helsinki, Finland. Nexstim Oyj operates under Medical Devices classification in Finland and is traded on Helsinki Exchange. It employs 34 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Nexstim Stock

Nexstim Oyj financial ratios help investors to determine whether Nexstim Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nexstim with respect to the benefits of owning Nexstim Oyj security.